640 related articles for article (PubMed ID: 28859077)
41. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
43. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
[TBL] [Abstract][Full Text] [Related]
44. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
Wang J; Shibayama Y; Zhang A; Ohsaki H; Asano E; Suzuki Y; Kushida Y; Kobara H; Masaki T; Wang Z; Nishiyama A
Br J Cancer; 2019 Jan; 120(2):229-237. PubMed ID: 30555158
[TBL] [Abstract][Full Text] [Related]
45. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
46. WNT5A encodes two isoforms with distinct functions in cancers.
Bauer M; Bénard J; Gaasterland T; Willert K; Cappellen D
PLoS One; 2013; 8(11):e80526. PubMed ID: 24260410
[TBL] [Abstract][Full Text] [Related]
47. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
[TBL] [Abstract][Full Text] [Related]
48. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
[TBL] [Abstract][Full Text] [Related]
49. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
[TBL] [Abstract][Full Text] [Related]
50. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
[TBL] [Abstract][Full Text] [Related]
51. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
52. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
53. Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/β-catenin signal pathway in colorectal cancer and predicts poor prognosis.
Zhou C; Li Y; Wang G; Niu W; Zhang J; Wang G; Zhao Q; Fan L
Pathol Res Pract; 2019 Jan; 215(1):57-67. PubMed ID: 30389319
[TBL] [Abstract][Full Text] [Related]
54. Vitamin D receptor prevents tumour development by regulating the Wnt/β-catenin signalling pathway in human colorectal cancer.
Yu J; Sun Q; Hui Y; Xu J; Shi P; Chen Y; Chen Y
BMC Cancer; 2023 Apr; 23(1):336. PubMed ID: 37046222
[TBL] [Abstract][Full Text] [Related]
55. Visinin-like 1, a novel target gene of the Wnt/β-catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer.
Tage H; Yamaguchi K; Nakagawa S; Kasuga S; Takane K; Furukawa Y; Ikenoue T
Cancer Med; 2023 Jun; 12(12):13426-13437. PubMed ID: 37096864
[TBL] [Abstract][Full Text] [Related]
56. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
Gao Y; Lu X
Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
[TBL] [Abstract][Full Text] [Related]
57. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
Mao D; Zhang X; Wang Z; Xu G; Zhang Y
Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
[TBL] [Abstract][Full Text] [Related]
58. Protein phosphatase 2A is essential to maintain active Wnt signaling and its Aβ tumor suppressor subunit is not expressed in colon cancer cells.
Carmen Figueroa-Aldariz M; Castañeda-Patlán MC; Santoyo-Ramos P; Zentella A; Robles-Flores M
Mol Carcinog; 2015 Nov; 54(11):1430-41. PubMed ID: 25252130
[TBL] [Abstract][Full Text] [Related]
59. miR‑576‑5p promotes epithelial‑to‑mesenchymal transition in colorectal cancer by targeting the Wnt5a‑mediated Wnt/β‑catenin signaling pathway.
Luo J; Liu L; Shen J; Zhou N; Feng Y; Zhang N; Sun Q; Zhu Y
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300054
[TBL] [Abstract][Full Text] [Related]
60. FTO-mediated ZNF687 accelerates tumor growth, metastasis, and angiogenesis in colorectal cancer through the Wnt/β-catenin pathway.
Li J; Li S; Xing X; Liu N; Lai S; Liao D; Li J
Biotechnol Appl Biochem; 2024 Apr; 71(2):245-255. PubMed ID: 37983718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
